Cystatin C tied to worse heart failure outcomes across ejection fraction spectrum
MedicalXpress
|
ماي 01, 2026
Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection fraction (EF) spectrum, according to a study published in Clinical Cardiology.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗